We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the Talks
-
1. Stem cells from the early embryo
- Prof. Janet Rossant
-
2. A chemical approach to controlling cell fate
- Prof. Sheng Ding
-
3. Niche oncogenesis
- Prof. David T. Scadden
-
4. Gene expression analysis of pluripotent stem cells
- Dr. Uma Lakshmipathy
-
5. Cellular therapies for neurological Injuries: bioreactors, potency, and coagulation
- Prof. Charles S. Cox, Jr.
-
6. The aging of mitotic cells: regeneration and aging
- Dr. Aubrey de Grey
-
7. Stem cells derived from amniotic fluid and placenta
- Prof. Anthony Atala
-
10. Cardiac stem cell therapy
- Prof. Joshua M. Hare
-
11. Stem and progenitor cells from peripheral blood
- Prof. Shay Soker
-
12. Stem cells from adipose tissue
- Dr. Adam J. Katz
-
13. Human hepatocyte isolation for clinical transplantation
- Prof. Stephen Strom
-
14. Building implantable human liver tissue from pluripotent stem cells
- Prof. David C. Hay
Printable Handouts
Navigable Slide Index
- Introduction
- Progenitor cells in peripheral blood
- Angiogenesis vs. Vasculogenesis
- Embryonic and adult vasculature
- Meet the endothelial cells
- Molecular angiogenesis
- Key regulators of angiogenesis
- Circulating endothelial progenitor cells
- EPCs are isolated from different sources
- In vitro EPC culture
- Unique cell surface markers for EPCs
- AC133 (CD133, Prominin)
- Embryonic and adult endothelial progenitors
- Bone marrow EPCs
- EPC mobilization: PlGF, MMP-9, sKitL
- Regulation of EPCs in neovascularization
- VEGF increases ECs in mouse peripheral blood
- VEGF increases EC colony formation
- The VEGF pathway
- Inhibiting VEGF signaling reduces CEC numbers
- Administration of VEGF encoding plasmid
- EPCs in burn and CABG patients
- Endothelial outgrowth colony formation in patients
- Bone marrow EPCs & genetically modified mice
- EPCs in Tie2-LacZ mice
- EPC in skin wounds
- Ischemia and angiogenesis
- EPCs from ischemic hindlimb and myocardium
- EPC incorporation in the cornea
- EPCs in mouse syngeneic colon cancer after BMT
- Cell therapy with EPCs
- Cell therapy: desired properties
- Sheep model to assay human stem cells
- Transplant human cells IP into sheep fetus
- EPC/ECFC isolation and phenotype
- EPC/ECFC transplantation
- Human ECFCs and sheep liver vasculature
- ECFC engraftment in sheep duodenum
- EPCs in & around the crypts of Lieberkühn (CLR)
- Crypt engrafted EPCs/ECFCs express CD134
- EPCs locate in areas where CD117+ cells reside
- EPCs contribute to the myofibroblast population
- Summary
Topics Covered
- Adult stem and progenitor cells have been found circulating in peripheral blood, allowing them to reach and integrate into all tissues
- Bone marrow is most likely the source of these cells, including endothelial progenitor cells (EPCs)
- Identification of circulating EPCs point to the possibility that vasculogenesis-mediated neovascularization, previously believed to be restricted to the embryonic stages, continues into adulthood
Talk Citation
Soker, S. (2014, March 5). Stem and progenitor cells from peripheral blood [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 24, 2024, from https://doi.org/10.69645/MNSM9018.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Shay Soker has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Haematology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Shay Soker, and
I'm a professor at the Wake Forest
Institute for Regenerative Medicine.
I'll be talking today
about stem and progenitor
cells from peripheral blood.
0:14
The bone marrow is,
most likely, the source
of stem and progenitor
cells in peripheral blood.
Hemangioblasts are the
embryonic precursors
of the hematopoietic
stem cells, or HSCs,
and they would give rise to the
committed hematopoietic cells.
Bone marrow mesenchymal
cells, or MSCs,
have multi-lineage
differentiation potentials.
Endothelial progenitor
cells, or EPCs,
are probably derived from
hemangioblast precursors
of hematopoietic
stem cells, but they
differentiate into
endothelial cells, or ECs.
My lecture will focus on EPCs and
their role in neo-vascularization
0:58
As a definition, I want to
highlight two processes.
The first is angiogenesis- -
the process of forming of new
vessels from pre-existing
blood vessels.
The second one is vasculogenesis-
- the assembly of capillaries
from endothelial progenitor cells.
And I will discuss
during the lecture,
the physiologic neo-vascularization
and pathologic neo-vascularization.
1:27
The embryonic development of the
vasculature, as I told you before-
- it starts with the
primary hepatoblasts
that differentiates
into angioblasts.
These angioblasts will
further go and differentiate
into endothelial cells to
form the primitive plexus,
and under the induction of other
angiogenic prospectus, which we'll
be discussing later on, they
form the mature vascular system.
Once this vascular system is
formed, it stays quiescent
under another set of growth
factors, one of which
is angiopoietin-1, or ANG-1.
Now, the process of
angiogenesis and vasculogenesis
also occurs during
adult life but is
mostly restricted to angiogenesis.
Upon stimulation
using growth factors
such as angiopoietin-2 and VEGF,
the endothelial cells are activated,
and then they form new vessels.
Recently- - and that's going to
be the topic of this lecture- -
it was shown that the immature
hemangioblasts and angioblasts may
also contribute to adult
neo-vascularization.